Champions Oncology, Inc. (CSBR) is a publicly traded Healthcare sector company. As of October 23, 2026, CSBR trades at $4.73 with a market cap of $67.51M and a P/E ratio of -72.14. CSBR moved -2.06% today. Year to date, CSBR is -28.53%; over the trailing twelve months it is -28.31%. Its 52-week range spans $4.59 to $11.06. Rallies surfaces CSBR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
CSBR financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CSBR recently traded at $4.73. Market cap is $67.51M. P/E ratio is -72.14. Revenue is $60.66M.
| Metric | Value |
|---|---|
| Price | $4.73 |
| Market Cap | $67.51M |
| P/E Ratio | -72.14 |
| EPS | $-0.07 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.06 |
| 52-Week Low | $4.59 |
| Volume | 15.97K |
| Avg Volume | 0 |
| Revenue (TTM) | $60.66M |
| Net Income | $-1.14M |
| Gross Margin | 49.82% |
CSBR analyst coverage data. Average price target: $0.00.